Myers' Cocktail: Ingredients, Doses and What the Evidence Actually Shows

In short: the Myers' cocktail is an intravenous infusion of magnesium, calcium, B-complex vitamins and vitamin C, formalised by Dr Alan Gaby from a recipe pioneered by the late Dr John Myers. It is given by vein to reach nutrient levels the gut cannot. Its appeal is mechanistic — controlled-trial evidence for the complete formula remains limited, and it is not an approved treatment for any disease.

Few protocols in integrative and wellness medicine are as widely offered, and as inconsistently defined, as the Myers' cocktail. It appears on the menu of IV clinics and pharmacies everywhere, often attached to a long list of promised benefits. Yet there is no single standard recipe, and the gap between what the infusion is marketed to do and what the evidence supports is wide. For clinicians, pharmacists and distributors, that gap is exactly where careful practice lives.

What is a Myers' cocktail?

The Myers' cocktail is an intravenous infusion of vitamins and minerals delivered directly into the bloodstream. It takes its name from Dr John Myers, a Baltimore physician who pioneered the use of injectable nutrients in the mid-twentieth century. Myers died in 1984, and — this is the part most accounts omit — he left no published formula. His exact ingredients and doses were never recorded.

What is used today is therefore not Myers' own recipe but a reconstruction. After Myers died, his patients sought continued treatment from Dr Alan Gaby, an integrative physician who standardised the infusion into what he called the "modified Myers' cocktail". Gaby's changes were substantial: he raised the magnesium roughly tenfold by using a 20% magnesium chloride solution, removed the dilute hydrochloric acid Myers had used, increased the vitamin C, and left out folic acid because it tends to precipitate when mixed with the other nutrients.

Gaby reported giving an estimated 15,000 infusions to between 800 and 1,000 patients over roughly eleven years. That is extensive clinical experience — but, by his own description, it is observational and anecdotal, not controlled data. The practical point is one of precision: when people say "Myers' cocktail" today, they mean Gaby's formulation. Myers' original remains unknown.

What's actually in a Myers' cocktail?

Because no legal standard recipe exists, Gaby's published formulation serves as the canonical reference. The table below sets out its components, typical amounts and the role each is intended to play. Vitamin C is supplied as ascorbate, while thiamine, riboflavin, niacinamide and the other B vitamins enter mainly through a combined B-complex preparation.

The mixture is typically drawn into a single syringe, diluted with sterile water to soften its hypertonicity, and given as a slow intravenous push over five to fifteen minutes. Real-world recipes vary widely between clinics, and many practitioners add glutathione as a separate push. None of this variation is governed by a formal standard — which is precisely why a clear reference formulation matters.

Why give it intravenously?

The rationale for the intravenous route is pharmacokinetic, and on this point the science is solid. Some nutrients simply cannot reach high blood concentrations when taken by mouth, because the gut absorbs them through saturable pathways. Vitamin C is the clearest example: oral intake plateaus the plasma level at roughly 1.5 mg/dL even at high doses, whereas intravenous administration can push it far higher — studies of very large infusions report peaks around 80 mg/dL. Magnesium behaves similarly; oral supplements barely move the serum level, while an IV can transiently double or triple it.

This is where careful language matters. Achieving a high serum concentration is established physiology. Whether that higher concentration translates into a clinical benefit for general wellness is a separate question — and it is the step the evidence has not confirmed. A blood level is an input, not an outcome. Keeping those two ideas apart is the difference between an accurate explanation and a marketing claim.

What does the clinical evidence show?

Here is the honest headline: there is little high-quality evidence that the Myers' cocktail, as a complete formula, is effective for any condition. The stronger data belong to individual components in specific clinical situations — which is not the same as evidence for the blend.

The only randomised controlled trial of the actual cocktail studied fibromyalgia. Published by Ali and colleagues in 2009, it enrolled 34 patients in a double-blind, placebo-controlled design over eight weeks. Both the infusion and the placebo groups improved — but there was no statistically significant difference between them. The authors concluded that the efficacy of the treatment, relative to placebo, was "as yet uncertain". The trial established that the infusion was feasible and tolerable, not that it worked.

Component-level evidence is a different matter, and it is important not to conflate the two. Intravenous magnesium given on its own is genuinely supported as an adjunct in severe acute asthma, though not in moderate cases. Intravenous magnesium for migraine is more mixed, with the strongest signal in patients who have aura or low magnesium levels. These findings concern magnesium as a single agent — they are not evidence for the Myers' cocktail. Authoritative reviewers, including the Merck Manual and Canada's CADTH, reach the same conclusion: the evidence for the infusion itself is insufficient.

For a clinician or partner, this grading is not a weakness to hide — it is the most useful thing on the page. It separates what can be said with confidence from what cannot, and it is exactly the balance that earns trust with informed audiences.

Is the Myers' cocktail safe?

Administered slowly by a trained clinician, the Myers' cocktail is generally well tolerated. It is not, however, risk-free, and the cautions are specific. A rapid magnesium infusion commonly produces a sensation of warmth or flushing, which can be a forerunner of a drop in blood pressure and, occasionally, fainting — the reason it should be given slowly, with a pause early in the first administration.

Several interactions deserve attention. Intravenous magnesium can drive potassium into cells, so there is an arrhythmia risk in patients who are already potassium-depleted — those on diuretics, or taking digoxin. Calcium is contraindicated alongside digoxin and must never be co-administered with ceftriaxone. Thiamine can rarely provoke an anaphylactic reaction. And while high-dose intravenous vitamin C can cause haemolysis in people with G6PD deficiency, the documented cases involved very large doses; the vitamin C in a Myers' cocktail is far lower, though prudent protocols still screen for the condition. Renal function should also be considered, as is standard for any intravenous nutrient. Above all, every one of these points underlines a single rule: this is a clinical procedure that requires professional administration and sterile technique, because any intravenous line carries a risk of bloodstream infection.

Regulation: what you can and can't claim

The regulatory position is unambiguous. The Myers' cocktail is not an approved medicinal product, and it is not a treatment for any disease. That distinction is not academic. In 2018 the US Federal Trade Commission brought its first-ever action against an IV-cocktail marketer, over unsupported claims that its infusions — explicitly including a "Myers cocktail" — could treat conditions such as cancer, multiple sclerosis, diabetes, fibromyalgia and heart failure. The resulting order required the company to tell consumers that the claims were not supported by science.

The lesson for anyone offering or supplying these infusions is straightforward. A Myers' cocktail can be described, accurately, as a micronutrient infusion administered under medical supervision. It cannot be described as a cure or a treatment for illness — those claims are both unsupported by evidence and a regulatory liability. As always, the specific rules vary by jurisdiction, and the current local position should be verified before marketing or supply.

The Myers' approach in the IVIXIR series

EFBA's reading of the Myers' template is reflected in IVIXIR MyerSence MD, a micronutrient concept built on the same backbone: vitamin C, magnesium chloride, and the full set of B vitamins — thiamine (B1), riboflavin (B2), nicotinamide (B3), dexpanthenol (B5), pyridoxine (B6) and B12. In other words, it covers the vitamin and magnesium core of Gaby's reference formula.

Two factual differences are worth noting, without drawing any efficacy conclusion. The concept contains no calcium — a recognised variant, since Gaby himself omitted calcium in patients with cardiac concerns. And its vitamin C is supplied as buffered sodium ascorbate rather than ascorbic acid, a gentler-pH form of the same active. A focused vitamin C concept, IVIXIR Sodium Ascorbate, sits alongside it for higher-strength ascorbate.

These are concepts for professional use, not medicinal products, and the way they are discussed follows the same discipline this article has tried to model: a plausible mechanism stated plainly, claims kept measured, and a clear line between what is established and what is not. That evidence-first posture is the foundation of our approach — and, with informed clinicians and partners, it is what builds a durable relationship.